How good is this!! From what I can understand yesterday QRX announced that the United States Patent and Trademark Office (USPTO) issued the Company a new patent, U.S. Patent #7,923,453, which expires in 2029. This patent covers a proprietary dosing algorithm for converting patients from intravenous opioid administration to orally administered MoxDuo IR, thereby more effectively and safely managing acute pain following surgery.
From what I can gather this is a great thing, can safely keep trialling the drug knowing now they have an updated patent there have been a few more buyers even at these high prices, maybe they think it is a safer gamble now with the current announcement, I was thinking we would see a few sell out at todays price, with July being the next big announcement I am holding on!! with a 3$ plus SP AUG, IMHO
QRX Price at posting:
$1.99 Sentiment: Hold Disclosure: Held
